Skip to main content
Mauna Kea Technologies logo

Mauna Kea Technologies — Investor Relations & Filings

Ticker · MKEA ISIN · FR0010609263 LEI · 5493007KMDG4MFIGJJ63 PA Manufacturing
Open in API
Filings indexed 778 across all filing types
Latest filing 2017-12-01 Share Issue/Capital Cha…
Country FR France
Listing PA MKEA

About Mauna Kea Technologies

https://www.maunakeatech.com/en/

Mauna Kea Technologies is a medical device company that develops and markets the Cellvizio® platform, a real-time in vivo cellular imaging system. The platform utilizes Confocal Laser Endomicroscopy (CLE) technology, enabling physicians to visualize tissue at the cellular level during medical procedures. This "optical biopsy" is performed using flexible, miniature fiber-optic probes (Confocal Miniprobes™) that are compatible with standard endoscopes. The core function of Cellvizio® is to provide immediate microscopic visualization, which aids in accelerating diagnosis, informing treatment strategies, and improving the precision of therapeutic interventions. Key applications include gastroenterology (for conditions such as Barrett's esophagus and pancreatic cysts), interventional pulmonology (lung cancer diagnostics), urologic oncology, and neurosurgery. The technology supports enhanced surgical procedures, including real-time margin assessment, and is being integrated with robotic surgery and AI-assisted imaging systems.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Share Issue/Capital Change Classification · 99% confidence The document announces the establishment of a new equity line financing agreement with Kepler Cheuvreux. Key phrases include 'nouvelle ligne de financement en fonds propres (Equity line financing)', 'lever 10,7 M€', and details about the issuance of shares based on market prices. This clearly relates to the company's fundraising and capital structure activities. This aligns directly with the definition for Capital/Financing Update (CAP). The document is an announcement, but the core subject is the financing mechanism itself, not just the announcement of a report (RPA) or a general regulatory filing (RNS).
2017-12-01 French
Communicated under the obligation to provide permanent information / Other communications
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces the 'RENEWS ITS EQUITY FINANCING FACILITY' and details the terms of a new agreement with Kepler Cheuvreux to allow for 'small successive capital increases'. It discusses potential financing amounts (€10.7 million), share issuance limits (2,250,000 shares), and the impact on existing share capital. These elements directly relate to fundraising, capital structure changes, and financing activities. This aligns perfectly with the definition for Capital/Financing Update (CAP). The document length is relatively short (3649 chars) and reads like a press release announcing a financial arrangement, not the full regulatory filing itself.
2017-12-01 English
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release dated November 16, 2017, announcing that the Croatian Health Insurance Fund now provides reimbursement coverage for the company's Cellvizio technology. This is a specific operational/business update concerning market access and pricing/reimbursement, rather than a mandatory financial filing (like 10-K, IR, or ER) or a general regulatory announcement (RNS). It does not fit the definitions for AGM-R, 10-K, AR, MANG, CT, CAP, DVA, DLST, DIRS, ER, SR, XLSX, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. It is closest to a general business update or announcement that might fall under Regulatory Filings (RNS) if no better category exists, but given the context of financial reporting categories, announcements about specific market access achievements or business milestones that aren't earnings or capital structure changes are often classified as general Regulatory Filings (RNS) when a more specific 'Business Update' category is unavailable. However, since this is a specific announcement about a reimbursement decision impacting revenue potential, it is best categorized as a general Regulatory Filing (RNS) as it is a non-standard, material announcement.
2017-11-16 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Earnings Release Classification · 99% confidence The document is a press release dated November 16, 2017, announcing that the Croatian Health Insurance Fund will now reimburse procedures using the Cellvizio® technology. This is a specific operational update concerning market access and reimbursement status in a particular country. It is not a comprehensive annual report (10-K), an interim report (IR), an earnings release (ER), or a management discussion (MDA). It is an announcement of a significant business development related to market acceptance and pricing/reimbursement, which often falls under general regulatory announcements or investor relations updates. Since it is a formal announcement about a specific business event (reimbursement coverage) and not a standard financial filing, the most appropriate category is Regulatory Filings (RNS) as a general announcement, or potentially Capital/Financing Update (CAP) if interpreted broadly as market access success, but RNS is the best fit for a general press release detailing operational milestones not covered by other specific codes. Given the content is a press release announcing a specific operational/market event, RNS is the most suitable general regulatory announcement category. FY 2017
2017-11-16 French
Rapport financier semestriel
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Rapport Financier Semestriel 2017' (2017 Half-Year Financial Report) and contains comprehensive financial statements, including the 'Etat de la situation financière' (Statement of Financial Position), income statements, and management discussion and analysis for the period ending June 30, 2017. It is a full interim report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H2 2017
2017-11-02 French
Rapport financier annuel
Annual Report Classification · 100% confidence The document is titled 'Rapport Financier Annuel 2016' (Annual Financial Report 2016) for Mauna Kea Technologies. It contains a comprehensive summary, management reports (Rapport de gestion), consolidated financial statements (Comptes consolidés), annual accounts (Comptes annuels), and audit reports (Rapport des commissaires aux comptes). This structure is characteristic of a full Annual Report (10-K equivalent in the French market). FY 2016
2017-11-02 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.